Q
Genomeweb,
Just as minimizing delays in diagnosis and treatment initiation shapes the outcome for an individual with cancer, so does an…
Just as minimizing delays in diagnosis and treatment initiation shapes the outcome for an individual with cancer, so does an…
Immunotherapy has reshaped clinical oncology. Immune checkpoint inhibitors, which enhance the immune system’s ability to target…
Abstract Immune checkpoint inhibitors (ICIs) have made important breakthrough in anti-tumor therapy, however, no single…
目前临床上主要通过PD-L1表达水平、肿瘤突变负荷(TMB)和微卫星不稳定状态这些标志物来寻找能从PD-1抑制剂治疗中受益的患者[1-3]。但是这些标志物的预测效果并不完美。 近日,来自法国波尔多大学医学院的A.